A laboratory in Beijing. China’s drug development industry could require an outsourcing capacity of 3 million litres compared with 100,000 litres currently. Photo: Bloomberg
China needs 30 times its outsourcing capacity to meet demand created by drug pricing reform, says Wuxi Biologics boss
- Hong Kong-listed company posts a 150 per cent increase in net profit for last year
A laboratory in Beijing. China’s drug development industry could require an outsourcing capacity of 3 million litres compared with 100,000 litres currently. Photo: Bloomberg
